1. Maevsky EI, Ivanitsky HR, Bogdanova L, Axenova O, Karmen NB, Pushkin SY, Maslennikov IA. Perftoran. In: Winslow RM, editor. Blood substitutes. London: Elsevier Academic Press; 2006. p. 288–97.
2. Maevsky EI. Emulsion of perfluoroorganic compounds for medical purposes, a process for the preparation thereof and methods for treating and preventing diseases with the use therof. United States Patent number 6,562,872 BI, 2003.
3. Vorobyev S. Perfluorocarbon gas transferring emulsion for medico-biological use, the composition and the production thereof a medicinal agent. European Patent Application number 06799621.5, 2006.
4. Verdin-Vasquez RC, Zapeda-Perez C, Ferra-Ferrer R, Chavez-Negrete A, Contreras F, Barroso-Aranda J. Use of perftoran emulsion to decrease allogenic blood transfusion in cardiac surgery: clinical trial. Artificial Cells Blood Substit Immobil Biotechnol. 2006;34:433–54.
5. Mayevskiy EI, Aksenova OG, Bogdanova LA, Moroz VV, SeninaRYa PSY, Ivanitsky GR. Analysis of clinical and adverse effects during phase I and II clinical studies of Perftoran. Russia Blood Bank Bull. 2001;4:2001.